Food and Drug Administration

Business • Health Care
F.D.A. issues emergency authorization for convalescent plasma as Covid-19 treatment
F.D.A. issues emergency authorization for convalescent plasma as Covid-19 treatment
Credit: Mehr News Agency / Wikimedia Commons (Creative Commons Attribution 4.0)

The US Food and Drug Administration has approved the use of convalescent plasma as Covid-19 treatment as the "known and potential benefits of the product outweigh the known and potential risks of the product." Even before the approval, around 70,000 people had been treated with convalescent plasma.

President Trump, after harshly criticising the speed of approval of treatments and vaccines, was pleased with the fast decision. "Today I am pleased to make a truly historic announcement in our battle against the China virus that will save countless lives. Today's action will dramatically increase access to this treatment," so the President.

Health
United States FDA authorize saliva-based Covid-19 test funded by NBA and NBPA
United States FDA authorize saliva-based Covid-19 test funded by NBA and NBPA
Credit: unsplash.com / NeONBRAND

A saliva-based Covid-19 test developed by the Yale University and funded by the National Basketball Association and the National Basketball Players Association has gotten emergency authorization by the United States Food and Drug Administration.

The new salvia test from Yale University only costs around $4, compared to $60 in the best cased for the competing salvia test that has been developed at Rutgers University lap. Both tests have been granted the same permission by the Food and Drug Administration.

Science • Medicine
Pfizer and US reach $1.95 billion deal for Covid-19 vaccine
Pfizer and US reach $1.95 billion deal for Covid-19 vaccine
Credit: Rhoda Baer (Photographer) / Public domain

The US government has agreed to pay $1.95 billion for 100 million Covid-19 vaccine doses to American pharmaceutical company Pfizer and German biotechnology company. The vaccine called BNT162 is currently still in development and early clinical trials. The agreement further states that the US could buy another 500 million doses, provided that the vaccine is both safe and effective as well as approved b the US Food and Drug Administration.

Regional News • Americas • United States
Approval of malaria drugs as Covid-19 treatment revoked in the US

The Unites States Food and Drug Administration (F.D.A.) has announced that they will revoke the emergency authorization for the usage of two malaria drugs as treatment for Covid-19. In the statement the F.D.A. states that the drugs are "unlikely to produce an antiviral effect".

Science • Medicine
Johnson & Johnson aiming to produce 1 billion doses of Covid-19 vaccines in 2021

Johnson & Johnson, multinational medical and pharmaceutical corporation, said in a statement on Sunday that they "aim to deliver 1 billion (Covid-19) vaccines next year". According to Paul Stoffels, chief scientific officer, the company is starting clinical trials in September and is planning to upscale their manufacturing to be able to start producing the vaccine late this year. Stoffel added “We will have some vaccine available this year, but it will depend on the authorities – the FDA and others – to decide whether it can be used earlier, before efficacy data are available".